Publikationen von W. Zieglgänsberger

Horlemann, J.; Zieglgänsberger, W.: Schmerzverarbeitung, Schmerzgedächtnis und Schlafqualität. Deutsche Medizinische Wochenschrift 134 (Suppl. 4), S. S127 - S131 (2009)

Leischner, U.; Zieglgänsberger, W.; Dodt, H. U.: Resolution of Ultramicroscopy and Field of View Analysis. PLoS ONE 4 (6), doi: 10.1371/journal.pone.0005785 (2009)

Rammes, G.; Starker, L. K.; Haseneder, R.; Berkmann, J.; Plack, A.; Zieglgänsberger, W.; Ohl, F.; Kochs, E. F.; Blobner, M.: Isoflurane anaesthesia reversibly improves cognitive function and long-term potentiation (LTP) via an up-regulation in NMDA receptor 2B subunit expression. Neuropharmacology 56 (3), S. 626 - 636 (2009)

Huge, V.; Rammes, G.; Beyer, A.; Zieglgänsberger, W.; Azad, S. C.: Activation of kappa opioid receptors decreases synaptic transmission and inhibits long-term potentiation in the basolateral amygdala of the mouse. European Journal of Pain 13 (2), S. 124 - 129 (2009)

Schoeffel, D.; Casser, H. R.; Bach, M.; Kress, H. G.; Likar, R.; Locher, H.; Steinleitner, W.; Strohmeier, M.; Brunner, H.; Treede, R. D. et al.; Zieglgänsberger, W.; Sandkühler, J.: Risikoabschätzung in der Schmerztherapie. Schmerz 22 (5), S. 594 - 603 (2008)

Deininger, K.; Eder, M.; Krämer, E. R.; Zieglgänsberger, W.; Dodt, H. U.; Dornmair, K.; Colicelli, J.; Klein, R.: The Rab5 guanylate exchange factor Rin1 regulates endocytosis of the EphA4 receptor in mature excitatory neurons. Proceedings of the National Academy of Sciences of the United States of America 105 (34), S. 12539 - 12544 (2008)

Rammes, G.; Zieglgänsberger, W.; Parsons, C. G.: The fraction of activated N-methyl-D-aspartate receptors during synaptic transmission remains constant in the presence of the glutamate release inhibitor riluzole. Journal of Neural Transmission 115 (8), S. 1119 - 1126 (2008)

Zieglgänsberger, W.: Current aspects of pain management - pain therapy defined by neuro-psychological mechanisms. Acta Neuropsychiatrica 20 (Suppl. 1), S. 43 - 43 (2008)

Azad, S. C.; Kurz, J.; Marsicano, G.; Lutz, B.; Zieglgänsberger, W.; Rammes, G.: Activation of CB1 specifically located on GABAergic interneurons inhibits LTD in the lateral amygdala. Learning & Memory 15 (3), S. 143 - 152 (2008)

Quasthoff, S.; Möckel, C.; Zieglgänsberger, W.; Schreibmayer, W.: Tolperisone: A typical representative of a class of centrally acting muscle relaxants with less sedative side effects. CNS Neuroscience & Therapeutics 14 (2), S. 107 - 119 (2008)

Nothdurfter, C.; Eisensamer, B.; Rein, T.; Rammes, G.; Uhr, M.; Henes, K.; Wagner, E. M.; Zieglgänsberger, W.; Holsboer, F.; Rupprecht, R.: Functional Consequences of the accumulation of psychopharmacological drugs in "lipid rafts" on ligand-gated ion channels. Pharmacopsychiatry 40 (5), S. 247 - 247 (2007)

Schierloh, A.; Deussing, J.; Wurst, W.; Zieglgänsberger, W.; Rammes, G.: Corticotropin-releasing factor (CRF) receptor type 1-dependent modulation of synaptic plasticity. Neuroscience Letters 416 (1), S. 82 - 86 (2007)

Dodt, H.-U.; Leischner, U.; Schierloh, A.; Jährling, N.; Mauch, C. P.; Deininger, K.; Deussing, J. M.; Eder, M.; Zieglgänsberger, W.; Becker, K.: Ultramicroscopy: three-dimensional visualization of neuronal networks in the whole mouse brain. Nature Methods 4 (4), S. 331 - 336 (2007)

Marsch, R.; Foeller, E.; Rammes, G.; Bunck, M.; Kössl, M.; Holsboer, F.; Zieglgänsberger, W.; Landgraf, R.; Lutz, B.; Wotjak, C. T.: Reduced anxiety, conditioned fear, and hippocampal long-term potentiation in transient receptor potential vanilloid type 1 receptor-deficient mice. The Journal of Neuroscience 27 (4), S. 832 - 839 (2007)

Ranft, A.; Kurz, J.; Becker, K.; Dodt, H.-U.; Zieglgänsberger, W.; Rammes, G.; Kochs, E.; Eder, M.: Nitrous oxide (N₂O) pre- and postsynaptically attenuates NMDA receptor-mediated neurotransmission in the amygdala. Neuropharmacology 52, S. 716 - 723 (2007)

Domenici, M. R.; Azad, S. C.; Marsicano, G.; Schierloh, A.; Wotjak, C. T.; Dodt, H.-U.; Zieglgänsberger, W.; Lutz, B.; Rammes, G.: Cannabinoid receptor type 1 located on presynaptic terminals of principal neurons in the forebrain controls glutamergic synaptic transmission. The Journal of Neuroscience 26 (21), S. 5794 - 5799 (2006)

Monory, K.; Massa, F.; Egertová, M.; Eder, M.; Blaudzun, H.; Westenbroek, R.; Kelsch, W.; Jacob, W.; Marsch, R.; Ekker, M. et al.; Long, J.; Rubenstein, J. L.; Goebbels, S.; Nave, K.-A.; During, M.; Klugmann, M.; Wölfel, B.; Dodt, H.-U.; Zieglgänsberger, W.; Wotjak, C. T.; Mackie, K.; Elphick, M. R.; Marsicano, G.; Lutz, B.: The endocannabinoid system controls key epileptogenic circuits in the hippocampus. Neuron 51, S. 455 - 466 (2006)

Eisensamer, B.; Uhr, M.; Meyr, S.; Gimpl, G.; Deiml, T.; Rammes, G.; Lambert, J. J.; Zieglgänsberger, W.; Holsboer, F.; Rupprecht, R.: Antidepressants and antipsychotic drugs colocalize with 5-HT₃ receptors in raft-like domains. The Journal of Neuroscience 25 (44), S. 10198 - 10206 (2005)

Becker, K.; Eder, M.; Zieglgänsberger, W.; Dodt, H. U.: WIN 55,212-2 decreases the spatial spread of neocortical excitation in vitro. NeuroReport 16 (9), S. 993 - 996 (2005)

Zieglgänsberger, W.; Berthele, A.; Tölle, T. R.: Understanding neuropathic pain. CNS Spectrums 10 (4), S. 298 - 308 (2005)